Proteomics of human biological fluids for biomarker discoveries: technical advances and recent applications

L Dayon, O Cominetti, M Affolter - Expert review of proteomics, 2022 - Taylor & Francis
Introduction Biological fluids are routine samples for diagnostic testing and monitoring.
Blood samples are typically measured because of their moderate invasive collection and …

Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future

DM Good, V Thongboonkerd, J Novak… - Journal of proteome …, 2007 - ACS Publications
Sparked by the article from Lescuyer and colleagues in a recent issue, we aim here to
further encourage interest in and discussion of clinically relevant biomarker research. We …

In-depth site-specific analysis of N-glycoproteome in human cerebrospinal fluid and glycosylation landscape changes in Alzheimer's disease

Z Chen, Q Yu, Q Yu, J Johnson, R Shipman… - Molecular & Cellular …, 2021 - ASBMB
As the body fluid that directly interchanges with the extracellular fluid of the central nervous
system (CNS), cerebrospinal fluid (CSF) serves as a rich source for CNS-related disease …

Biosynthetic origin of natural products isolated from marine microorganism–invertebrate assemblages

TL Simmons, RC Coates, BR Clark… - Proceedings of the …, 2008 - National Acad Sciences
In all probability, natural selection began as ancient marine microorganisms were required
to compete for limited resources. These pressures resulted in the evolution of diverse …

Recent advances in quantitative neuroproteomics

GE Craft, A Chen, AC Nairn - Methods, 2013 - Elsevier
The field of proteomics is undergoing rapid development in a number of different areas
including improvements in mass spectrometric platforms, peptide identification algorithms …

Amyotrophic lateral sclerosis multiprotein biomarkers in peripheral blood mononuclear cells

G Nardo, S Pozzi, M Pignataro, E Lauranzano… - PloS one, 2011 - journals.plos.org
Background Amyotrophic lateral sclerosis (ALS) is a fatal progressive motor neuron disease,
for which there are still no diagnostic/prognostic test and therapy. Specific molecular …

Proteomics of human cerebrospinal fluid: discovery and verification of biomarker candidates in neurodegenerative diseases using quantitative proteomics

AC Kroksveen, JA Opsahl, TT Aye, RJ Ulvik… - Journal of …, 2011 - Elsevier
There is an urgent need for novel biomarkers that can be used to improve the diagnosis,
predict the disease progression, improve our understanding of the pathology or serve as …

Common data elements for traumatic brain injury: recommendations from the biospecimens and biomarkers working group

GT Manley, R Diaz-Arrastia, M Brophy, D Engel… - Archives of physical …, 2010 - Elsevier
Manley GT, Diaz-Arrastia R, Brophy M, Engel D, Goodman C, Gwinn K, Veenstra TD, Ling G,
Ottens AK, Tortella F, Hayes RL. Common data elements for traumatic brain injury …

Biomarker discovery in neurodegenerative diseases: a proteomic approach

M Shi, WM Caudle, J Zhang - Neurobiology of disease, 2009 - Elsevier
Biomarkers for neurodegenerative disorders are essential to facilitate disease diagnosis,
ideally at early stages, monitor disease progression, and assess response to existing and …

Boost-DiLeu: Enhanced Isobaric N,N-Dimethyl Leucine Tagging Strategy for a Comprehensive Quantitative Glycoproteomic Analysis

D Wang, M Ma, J Huang, TJ Gu, Y Cui, M Li… - Analytical …, 2022 - ACS Publications
Intact glycopeptide analysis has been of great interest because it can elucidate glycosylation
site information and glycan structural composition at the same time. However, mass …